Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInnovaderm Research Inc.

About this trial

The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.

Subject must be willing to comply with all study procedures and must be available for the duration of the study.

Male or female subject aged 18 years or older, at the time of consent.

Subject is in good general health, according to the investigator's judgment.

Disqualifiers

Subject is a female who is pregnant or who is planning to become pregnant during the study.

Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.

Trial population

Approximately 200 healthy volunteers and approximately 300 subjects with acne, atopic dermatitis (AD), chronic hand eczema (CHE), hidradenitis suppurativa (HS), palmoplantar pustulosis (PPP), and/or psoriasis will be included in this study.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • Blood samples collection

    Procedure/Surgery

    biomarkers and optional genetic analysis

  • Oral samples collection

    Procedure/Surgery

    biomarkers analysis

  • Hair samples collection

    Procedure/Surgery

    biomarkers analysis

  • Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)

    Procedure/Surgery

    biomarkers analysis

  • Skin surface material samples

    Procedure/Surgery

    biomarkers analysis

  • Drainage fluid samples collection

    Procedure/Surgery

    biomarkers analysis

  • Stool samples collection

    Procedure/Surgery

    biomarkers analysis

Treatment groups

500 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Group A: Healthy volunteers7 interventions
Group B: Acne7 interventions
Group C: AD7 interventions
Group D: CHE7 interventions
Group E: HS7 interventions
Group F: PPP7 interventions
Group G: Psoriasis7 interventions

Trial outcomes

Primary outcomes

1

Untargeted biomarker approach with gene expression profile of skin samples

Time frame
Day 1
2

Exploratory biomarker and gene expression analyses.

Time frame
Day 1

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.